Showing 4871-4880 of 5646 results for "".
- Lineage Cell Therapeutics Reinitiates Patient Enrollment in Clinical Study of OpRegen for the Treatment of Dry AMD With GAhttps://modernod.com/news/lineage-cell-therapeutics-reinitiates-patient-enrollment-in-clinical-study-of-opregen-for-the-treatment-of-dry-amd-with-geographic-atrophy/2477911/Lineage Cell Therapeutics announced that it has restarted patient enrollment in a phase 1/2a clinical study of its lead product candidate, OpRegen, a retinal pigment epithelium (RPE) cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD),
- Santen and Orbis International Join Forces to Expand Access to Training for Eye Care Professionals Through Telemedicine Platformhttps://modernod.com/news/santen-and-orbis-international-join-forces-to-expand-access-to-training-for-eye-care-professionals-through-telemedicine-platform/2477910/Santen Pharmaceutical and Orbis International announced a partnership to develop a suite of digital training tools that will continue to help eye care professionals around the world build their skills. Through the 3-year, global partnership, Orbis and Santen will create online courses, live surgi
- Fitbit Joins Growing List of Companies Offering Back-to-Work Health Screening Toolshttps://modernod.com/news/fitbit-joins-growing-list-of-companies-offering-back-to-work-health-screening-tools/2477908/Device maker Fitbit is the latest technology company to jump into the back-to-work business, according to a FierceHealthcare
- NTC Grants License and Distribution Rights in Israel to Taro Pharmaceutical for Ophthalmic Quinolone Antibiotichttps://modernod.com/news/ntc-grants-license-and-distribution-rights-in-israel-to-taro-pharmaceutical-for-ophthalmic-quinolone-antibiotic/2477905/NTC has granted exclusive license and distribution rights to one of its research and development products, a fixed combination in eye drops, in Israel to Taro Pharmaceutical Industries. The product combines a quinolone antibiotic with an anti-inflammatory steroid
- NYU Langone Names New Chair of Ophthalmologyhttps://modernod.com/news/nyu-langone-names-new-chair-of-ophthalmology/2477903/Kathryn A. Colby, MD, PhD, an internationally renowned physician–scientist, has been appointed chair of the Department of Ophthalmology at NYU Langone Health. She assumes her new post this fall. Dr. Colby is currently the Louis Block Professor and chair of the Department of Ophthalmology a
- Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Retinitis Pigmentosahttps://modernod.com/news/bionic-sight-llc-doses-first-patient-in-a-phase-1-2-clinical-trial-of-a-new-investigational-treatment-for-blindness-caused-by-retinitis-pigmentosa/2477902/Bionic Sight announced that it has dosed the first patient in the company’s phase 1/2 clinical trial of BS01, an optogenetic gene therapy for patients with retinitis pigmentosa. This is an important step toward bringing BS01 forward as a treatment to enable patients with retinal degenerative dise
- FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquinehttps://modernod.com/news/fda-revokes-emergency-use-authorization-for-chloroquine-and-hydroxychloroquine/2477896/The FDA revoked the emergency use authorization (EUA) that allowed for chloroquine and hydroxychloroquine to be used to treat certain hospitalized patients with COVID-19, according to an FDA news release. The agency determined that th
- Scientists Rescue ‘Mini Retinas’ From Eye Disease Via New Gene Therapy Approachhttps://modernod.com/news/scientists-rescue-mini-retinas-from-eye-disease-via-new-gene-therapy-approach/2477895/Scientists have developed a new gene therapy approach that offers promise for one day treating retinitis pigmentosa, according to Trinity College Dublin. Researchers from Trinity College and University College London (UCL) teamed up to pool their expertise in ge
- Orbis International Launches Virtual Flying Eye Hospital Training Programshttps://modernod.com/news/orbis-international-launches-virtual-flying-eye-hospital-training-programs/2477894/Orbis International launched virtual Flying Eye Hospital training programs through its telemedicine platform, Cybersight, which provides online training and mentorship for eye care professionals in low- and middle-income countries. The inaugural program has been designed for eye care professional
- AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doseshttps://modernod.com/news/astrazeneca-to-supply-europe-up-to-400-million-covid-19-vaccine-doses/2479514/AstraZeneca announced that it has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford’s COVID-19 experimental vaccine, with deliveries starting by the end of this year. CEO Pascal Soriot remarked that ̶